The 20 Best Viral Hemorrhagic Fever Doctors Near Me in Baltimore, MD

Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is rated as an Elite provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine.

Amita Gupta is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gupta is board certified in American Board Of Internal Medicine.

"Albert W. Wu is Professor of Health Policy and Management and Medicine, with joint appointments in Epidemiology, International Health, Medicine and Surgery. He received BA and MD degrees from Cornell University, and completed an Internal Medicine residency at the Mount Sinai Hospital and UC San Diego. He was a Robert Wood Johnson Clinical Scholar at UCSF and received an MPH from UC Berkeley. His research and teaching focus on patient outcomes and quality of care. He was the first to measure the quality of life impact of antiretroviral therapy in HIV clinical trials. He developed the MOS-HIV health survey, and other questionnaires to measure quality of life, adherence, satisfaction, attitudes and behaviors for people with chronic disease. He was co-founder and director of the outcomes research committee of the AIDS Clinical Trials Group of the NIH, and President of the International Society for Quality of Life. He advises many US and international organizations on PRO methods. He is director of the Johns Hopkins Center for Health Services and Outcomes Research, He has studied the handling of medical errors since 1988, was a member of the Institute of Medicine committee on identifying and preventing medication errors, and was Senior Adviser for Patient Safety to WHO in Geneva. His current research is on incorporating PROs into the electronic health record, PRO-performance measures for primary care, supporting healthcare workers after adverse events, and creating a network community based organizations. He has authored over 400 peer review publications. and is co-author of the recent book ""New Horizons in Patient Safety, Understanding Communication. He leads the PhD program in health services research, the Masters of Applied Science in Patient Safety & Healthcare Quality, and the Certificate program in Quality, Patient Safety and Outcomes Research in the Johns Hopkins Bloomberg School of Public Health. He maintains a clinical practice in general internal medicine.". Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, HIV/AIDS, and Sepsis. Dr. Wu is board certified in American Board Of Internal Medicine.

Lisa Maragakis, M.D., M.P.H., FSHEA, FIDSA is a professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is the Senior Director of Infection Prevention, for The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program. Her research interests are the epidemiology, prevention and control of healthcare-acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2022 Update of the Compendium of Strategies to Prevent Healthcare-Associated Infections, and as Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC). Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, Severe Acute Respiratory Syndrome (SARS), and Sepsis. Dr. Maragakis is board certified in American Board Of Internal Medicine.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.

Dr. Noreen Hynes has over 35 years of medical and public health experience in both international and domestic settings. Her career has encompassed basic and applied research, epidemiology, public health, clinical medicine, and the regulatory aspects of medical countermeasures for emerging and infectious diseases and high-consequence pathogens. Dr. Hynes has been affiliated with The Johns Hopkins Medical Institutions and the Schools of Medicine and Public Health University since 1997. She is currently an Associate Professor of Medicine (part-time) in the School of Medicine, Division of Infectious Diseases, and is jointly appointed in the School of Public Health in the Department of International Health. Since 2009, Dr. Hynes has served as the director of the Geographic Medicine Center in the Division of Infectious Diseases in the Johns Hopkins School of Medicine, as the Medical Director of the Johns Hopkins Tropical & Travel Medicine Service, and as the Baltimore Site Director for the CDC-sponsored GeoSentinel Surveillance System. Dr. Hynes serves as the Director of Research and the Associate Medical Director of the Johns Hopkins Hospital BioContainment Unit. She also serves as the co-director of the Infectious Disease concentration in the Johns Hopkins Master of Public Health degree program. Dr. Hynes' research interests focus on infectious diseases at the clinical-public health interface in resource-constrained settings in both tropical and temperate regions. Her research focuses on tropical diseases, including those that or zoonoses or high-consequence pathogens. Her research focuses on these pathogens including examining deliberate and naturally-occurring exposures/outcomes, the epidemiology and control of emerging infectious diseases, and collaboration on vaccine clinical trials conducted by the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health. Dr. Hynes is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. Her clinical expertise encompasses Viral Hemorrhagic Fever, Ebola Virus Disease, Dengue Fever, and COVID-19. Dr. Hynes is board certified in American Board Of Internal Medicine.

Dr. Kawsar Talaat is an assistant scientist and holds a joint appointment in medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious diseases and international health. Dr. Talaat earned her M.D. from the University of Washington School of Medicine. She completed her residency at the Medical College of Wisconsin and performed a fellowship in infectious diseases at the National Institutes of Health Warren Grant Magnuson Clinical Center. Her research interests include international health, vaccines, avian influenza, pandemic influenza and parasitology. Dr. Talaat is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Diarrhea, Shigellosis, Flu, and E Coli Enteritis. Dr. Talaat is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

John Beigel is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Beigel is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Flu, Severe Acute Respiratory Syndrome (SARS), Zika Virus Disease, and Togaviridae Disease.

Bridgette Billioux is a primary care provider, practicing in Neurologist in Baltimore, Maryland. Dr. Billioux is rated as an Advanced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Ebola Virus Disease, Encephalitis, HTLV-1 Associated Myelopathy, and Myelitis.

Jakub Simon is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Simon is rated as an Advanced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ebola Virus Disease, Cholera, Viral Hemorrhagic Fever, and Shigellosis.

Kirsten Lyke is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Lyke is rated as an Advanced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Malaria, Primary Amebic Meningoencephalitis, Rabies, and Viral Hemorrhagic Fever.

Joel Chua is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Chua is rated as an Advanced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Hepatitis, and Osteomyelitis.

Emily Erbelding is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Erbelding is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. Her clinical expertise encompasses Flu, Acute Flaccid Myelitis (AFM), Gonorrhea, and Coccidioidomycosis.

Niranjan Bhat is a Pediatric Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Bhat is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Tetanus, Pertussis, Yellow Fever, and H Influenzae Meningitis.

Wilbur Chen is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Cholera, Shigellosis, Typhoid Fever, and Flu.

Melissa Mcdiarmid is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Mcdiarmid is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Ear Barotrauma, Severe Acute Respiratory Syndrome (SARS), Hepatitis A, and Ebola Virus Disease.

Mohammad Sajadi is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Sajadi is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Hepatitis C, COVID-19, and Bone Marrow Aspiration.

Milagritos Tapia is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Tapia is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Parainfluenza, Meningitis, Measles, and Bacterial Meningitis.

Robert Edelman is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Edelman is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. His clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, and Malaria.

Luciana Borio is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Borio is rated as an Experienced provider by MediFind in the treatment of Viral Hemorrhagic Fever. Her clinical expertise encompasses Ebola Virus Disease, Viral Hemorrhagic Fever, Myelitis, and AIDS Dysmorphic Syndrome.